Amentum (AMTM) Raymond James & Associates’ 46th Annual Institutional Investors Conference 2025 summary
Event summary combining transcript, slides, and related documents.
Raymond James & Associates’ 46th Annual Institutional Investors Conference 2025 summary
16 Dec, 2025Company background and recent transformation
Originated as a $4B PE-backed spin-out from AECOM, focused on U.S. government services.
Expanded to $8.2B revenue by 2023 through two major acquisitions, with global operations.
Pursued a Reverse Morris Trust (RMT) with Jacobs' CMS business to unlock shareholder value.
Integration planning began pre-close, with a 50/50 team from both companies.
Announced new vision, mission, values, and org structure to all employees before deal close.
Integration strategy and synergy realization
Focused on merging cultures, integrating systems, and unifying business development.
Integration management office established to accelerate post-close execution.
Cost synergy target set at $60M net, with delivery on track for the next 18 months.
Revenue synergies pursued by cross-selling technology solutions and leveraging enterprise scale.
Created an enterprise-level business development function for large bids ("mega deals").
Market positioning and growth opportunities
80% of revenue from U.S. government, less concentrated than peers.
Critical mission focus in national security, environmental remediation, and infrastructure.
Expanding into commercial and international markets, especially Europe.
Positioned for growth in missile defense, UAVs, and nuclear energy engineering.
Technology showcase and productization efforts to drive cross-sell and margin improvement.
Latest events from Amentum
- Accelerating growth in nuclear, space, and digital markets drives robust cash flow and margin expansion.AMTM
47th Annual Raymond James Institutional Investor Conference4 Mar 2026 - Net income jumped 267% to $44M on $3.24B revenue, with backlog up 4% to $47.2B.AMTM
Q1 202610 Feb 2026 - All director nominees, audit firm ratification, and executive compensation were approved by majority vote.AMTM
AGM 20269 Feb 2026 - A $14B global leader targets $1.1B EBITDA, 8% margin, and strong growth post-merger.AMTM
Investor Day 20242 Feb 2026 - FY24 pro forma revenue and EBITDA grew post-merger; FY25 guidance and $45B backlog affirmed.AMTM
Q4 202411 Jan 2026 - Board recommends electing 13 directors, ratifying auditor, and approving executive pay.AMTM
Proxy Filing19 Dec 2025 - Annual meeting to vote on directors, auditor, and executive pay amid strong performance and governance.AMTM
Proxy Filing19 Dec 2025 - Q1 FY2025 delivered revenue growth, $12M net income, and record backlog, reaffirming guidance.AMTM
Q1 202517 Dec 2025 - Proxy covers director elections, auditor ratification, compensation, and ESG priorities.AMTM
Proxy Filing2 Dec 2025